Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin PK in Japanese Epileptic Patients with Renal Impairment
NCT00785772Phase 4Terminated
- Sponsor
- Viatris
- Start
- Mar 2010
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of gabapentin in epilepsy (3 arms), sponsored by Viatris. Primary endpoints: Observed Plasma Gabapentin Concentration at Day 15, Ratio of Observed Plasma Gabapentin Concentration to Predicted Plasma Gabapentin Concentration Based on Population Pharmacokinetics Model at Day 15 and 1 more. Started Mar 2010; status: terminated.
02
Drugs
gabapentin
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00785772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00785772.